1Petty RE,Southwood TR,Baum J,et al.Revision of the proposed classification criteria for juvenile idiopathic arthritis.J Rheumatol,1998,25:1991-1994.
2Petty RE,Southwood TR,Manners P,et al.International league of associations for rheumatology classification of juvenile idiopathic arthritis:second revision,edmonton.J Rheumatol,2004,31:390-392.
4Yilmaz M,Kendirli SG,Altintas D,et al.Cytokine levels in serum of patients with juvenile rheumatoid arthritis.Clin Rheumatol,2001,20:30-35.
5Neurath MF,Hildner K,Becker C,et al.Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA):a mechanism for methotrexate-mediated immunosuppression.Clin Exp Immunol,1999,115:42-55.
6Smolewska E,Brozik H,Smolewski P,et al.Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis.Ann Rheum Dis,2003,62:761-763.
7Smolewska E,Brozik H,Smolewski P,et al.Regulation of peripheral blood and synovial fluid lymphocyte apoptosis in juvenile idiopathic arthritis.Scand J Rheumatol,2004,33:7-12.
8Carrasco R,Smith JA,Lovell D.Biologic agents for the treatment of juvenile rheumatoid arthritis:current status.Paediatr Drugs,2004,6:137-146.
